Public procurement notice: Prior Information Notice Without Call For Competition
Published: 2020-09-29
Buyer: Procurement and Logistics Service
Country: UK
Contract type: Supplies
CPV classification: 33000000 | 33100000

Technical requirements: Lääketieteelliset laitteet, farmaseuttiset valmisteet ja henkilökohtaiseen hygieniaan liittyvät tuotteet
A point of care testing Hb A1c service is required across clinical locations in Northern Ireland using POCT analysers suitable for professional use.
BSO Procurement and Logistics Service (PaLS), on behalf of the Belfast Health and Social Care Trust, Western Health and Social Care Trust, Northern Health and Social Care Trust, South Eastern Health and Social Care Trust and Southern Health and Social Care Trust wish to seek engagement with the marketplace to ascertain the market’s capabilities for the supply, delivery, installation, commissioning and maintenance of POC Hb A1c Testing.
Glycated Haemoglobin A1c (Hb A1c) is the biochemical marker of choice to assess the risk of long term secondary diabetic complications such as retinopathy, neuropathy and nephropathy. Point of Care Testing (POCT) for Hb A1c offers some advantages over lab based measurement in terms of result availability and sample volume. The Northern Ireland (NI) Trusts require a fully connected POCT service at clinical locations, using POCT analysers suitable for professional use.
The Trusts wish to investigate what is currently available in the marketplace with regard to functional attributes and characteristics of current ‘POC Hb A1c Testing’ and wish to ensure that any future Tender fully recognises existing and future operational opportunities. To this end, an open invitation is being extended to all interested parties to declare their interest in participating in a product awareness session.
Product awareness session is scheduled to take place via video conference 26 October 2020 and/or 27 October 2020. It is likely the Trusts will only be able to facilitate two full days of supplier engagement sessions, therefore places will be limited and it may not be possible to accommodate all interested suppliers. Sessions will be allocated on a first come first served basis.
Product awareness session will be an opportunity for relevant suppliers to present to a panel of potential users. The presentation will be scheduled to last approximately 45 minutes per presenting organisation and will be required to:
3) to be available to respond to questions or clarifications from attendees following demonstration and presentation covering all aspects of system functionality, connectivity, installation, commissioning, training and after sales servicing. The overall purpose of the session will be to update, educate and inform attendees of what is currently available in the marketplace and to assist on potential functional characteristics which could form part of the future tender specification. Your participation in any future tender is in no way connected to or dependent upon your attendance at this product awareness session. Product awareness session is scheduled to take place via video conference given current Covid-19 situation, on Monday 26 October 2020 or Tuesday 27 October 2020. Specific appointment times will be communicated to each supplier following the closing date of this declaration of interest. Only those companies, who can confirm their ability to provide, demonstrate and support 'Point of Care Testing Hb A1c' will be invited to attend the product awareness session. What you need to do now:
3) submit your completed declaration of Interest form by emailing palsgransha.sourcing@hscni.net before the deadline at 16.00 Wednesday 14 October 2020;
4) ensure that you will be available to attend on Monday 26 October 2020 or Tuesday 27 October 2020 and be able to present principles of a working model.